Literature DB >> 24544484

Antibacterial properties of volatile principles from Alpinia galanga and Acorus calamus.

I C CHOPRA, B N KHAJURIA, C L CHOPRA.   

Abstract

Keywords:  BACTERIA/effect of drugs on; PLANTS/effects

Mesh：

Substances：

Year:  1957        PMID： 24544484

Source DB:  PubMed          Journal:  Antibiot Chemother (Northfield)        ISSN： 0570-3123


× No keyword cloud information.
  5 in total

1.  Biological evaluation of plants of Laos used in the treatment of tuberculosis in Lao traditional medicine.

Authors:  Bethany G Elkington; Bounhong Southavong; Kongmany Sydara; Onevilay Souliya; Manoluck Vanthanouvong; Kongdeuane Nettavong; Bounleuth Thammachack; Dennis H Pak; Mary C Riley; Scott G Franzblau; D Doel Soejarto
Journal:  Pharm Biol       Date:  2009-01       Impact factor: 3.503

2.  Phytoconstituents from Alpinia purpurata and their in vitro inhibitory activity against Mycobacterium tuberculosis.

Authors:  Oliver B Villaflores; Allan Patrick G Macabeo; Dietmar Gehle; Karsten Krohn; Scott G Franzblau; Alicia M Aguinaldo
Journal:  Pharmacogn Mag       Date:  2010-10       Impact factor: 1.085

Review 3.  Significance of gingers (Zingiberaceae) in Indian System of Medicine - Ayurveda: An overview.

Authors:  Konickal Mambetta Prabhu Kumar; Gopinathan Ramanikutty Asish; Mamiyil Sabu; Indira Balachandran
Journal:  Anc Sci Life       Date:  2013-04

4.  In Vitro Activities of Enantiopure and Racemic 1'-Acetoxychavicol Acetate against Clinical Isolates of Mycobacterium tuberculosis.

Authors:  Saradee Warit; Kamolchanok Rukseree; Therdsak Prammananan; Poonpilas Hongmanee; Pamaree Billamas; Sarinya Jaitrong; Angkana Chaiprasert; Birgit U Jaki; Guido F Pauli; Scott G Franzblau; Prasit Palittapongarnpim
Journal:  Sci Pharm       Date:  2017-09-18

5.  Evaluating the anti Mycobacterium tuberculosis activity of Alpinia galanga (L.) Willd. axenically under reducing oxygen conditions and in intracellular assays.

Authors:  Pooja Gupta; Purva Bhatter; Desiree D'souza; Monica Tolani; Poonam Daswani; Pundarikakshudu Tetali; Tannaz Birdi
Journal:  BMC Complement Altern Med       Date:  2014-03-04       Impact factor: 3.659
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.